Silverarc Capital Management, LLC Evogene Ltd. Transaction History
Silverarc Capital Management, LLC
- $353 Million
- Q2 2024
A detailed history of Silverarc Capital Management, LLC transactions in Evogene Ltd. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 3,079,739 shares of EVGN stock, worth $7.05 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
3,079,739
Previous 3,085,503
0.19%
Holding current value
$7.05 Million
Previous $2.31 Million
13.53%
% of portfolio
0.57%
Previous 0.78%
Shares
13 transactions
Others Institutions Holding EVGN
# of Institutions
26Shares Held
3.9MCall Options Held
400Put Options Held
0-
Morgan Stanley New York, NY218KShares$500,2610.0% of portfolio
-
Eidelman Virant Capital117KShares$267,9300.07% of portfolio
-
Lpl Financial LLC Fort Mill, SC67.3KShares$154,1970.0% of portfolio
-
Ubs Group Ag66KShares$151,1510.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA61.4KShares$140,4930.0% of portfolio
About Evogene Ltd.
- Ticker EVGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,202,000
- Market Cap $94.4M
- Description
- Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...